Inventor · disambiguated record
Shiro Shibayama
Also filed as: SHIBAYAMA SHIRO
52 granted patents·34 pending applications·2,496 citations·filing 1998–2025
99Inventor score
Top patents by PatentIndex Score
86 records- 0198US9439962B2Immunopotentiative compositionONO PHARMACEUTICAL CO·Filed 2016·Granted Sep 13, 2016·67 cites·30 claims
- 0298US9402899B2Immunopotentiative compositionONO PHARMACEUTICAL CO·Filed 2014·Granted Aug 2, 2016·93 cites·67 claims
- 0398US9393301B2Immunopotentiative compositionONO PHARMACEUTICAL CO·Filed 2016·Granted Jul 19, 2016·76 cites·30 claims
- 0498US9073994B2Immunopotentiative compositionONO PHARMACEUTICAL CO·Filed 2014·Granted Jul 7, 2015·217 cites·30 claims
- 0598US9067999B1Immunopotentiative compositionONO PHARMACEUTICAL CO·Filed 2015·Granted Jun 30, 2015·173 cites·30 claims
- 0698US8728474B2Immunopotentiative compositionHONJO TASUKU·Filed 2010·Granted May 20, 2014·305 cites·17 claims
- 0798US8168179B2Treatment method using anti-PD-L1 antibodyHONJO TASUKU·Filed 2009·Granted May 1, 2012·349 cites·8 claims
- 0898US7595048B2Method for treatment of cancer by inhibiting the immunosuppressive signal induced by PD-1ONO PHARMACEUTICAL CO·Filed 2003·Granted Sep 29, 2009·473 cites·4 claims
- 0998US7563869B2Substance specific to human PD-1ONO PHARMACEUTICAL CO·Filed 2004·Granted Jul 21, 2009·204 cites·4 claims
- 1097US7858746B2Substance that specifically recognizes PD-1ONO PHARMACEUTICAL CO·Filed 2008·Granted Dec 28, 2010·60 cites·2 claims
- 1196US8246955B2Substance specific to human PD-1HONJO TASUKU·Filed 2011·Granted Aug 21, 2012·54 cites·5 claims
- 1296US7998479B2Substance specific to human PD-1ONO PHARMACEUTICAL CO·Filed 2009·Granted Aug 16, 2011·57 cites·2 claims
- 1395US8168783B2Chemokine receptor antagonists and use thereofKOKUBO MASAYA·Filed 2006·Granted May 1, 2012·49 cites·3 claims
- 1493US7951816B2Compound containing basic group and use thereofONO PHARMACEUTICAL CO·Filed 2005·Granted May 31, 2011·29 cites·11 claims
- 1592US8951518B2Substance specific to human PD-1HONJO TASUKU·Filed 2012·Granted Feb 10, 2015·16 cites·4 claims
- 1691US8460886B2Use of an efficacy marker for optimizing therapeutic efficacy of an anti-human PD-1 antibody on cancersSHIBAYAMA SHIRO·Filed 2009·Granted Jun 11, 2013·37 cites·18 claims
- 1791US8153625B2Nitrogen-containing heterocyclic compounds and medicinal use thereofHABASHITA HIROMU·Filed 2010·Granted Apr 10, 2012·29 cites·7 claims
- 1889US10647770B2Therapeutic agent for autoimmune diseases comprising PD-1 agonistONO PHARMACEUTICAL CO·Filed 2017·Granted May 12, 2020·5 cites·21 claims
- 1989US9783609B2Substance specific to human PD-1ONO PHARMACEUTICAL CO·Filed 2014·Granted Oct 10, 2017·8 cites·8 claims
- 2089US8216996B2Multimer of extracellular domain of cell surface functional moleculeMINATO NAGAHIRO·Filed 2007·Granted Jul 10, 2012·16 cites·9 claims
- 2189US7759336B2Nitrogen-containing heterocyclic compounds and medicinal use thereofONO PHARMACEUTICAL CO·Filed 2003·Granted Jul 20, 2010·36 cites·8 claims
- 2288US9701749B2Therapeutic agent for autoimmune diseases comprising PD-1 agonistSHIBAYAMA SHIRO·Filed 2012·Granted Jul 11, 2017·23 cites·19 claims
- 2388US8574872B2Multimer of extracellular domain of cell surface functional moleculeMINATO NAGAHIRO·Filed 2012·Granted Nov 5, 2013·12 cites·13 claims
- 2485US7638281B2Polypeptide, cDNA encoding the same and use of themONO PHARMACEUTICAL CO·Filed 2007·Granted Dec 29, 2009·2 cites·9 claims
- 2584US12091461B2Bispecific antibodyONO PHARMACEUTICAL CO·Filed 2021·Granted Sep 17, 2024·1 cites·36 claims
- 2684US8003642B2Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredientONO PHARMACEUTICAL CO·Filed 2007·Granted Aug 23, 2011·9 cites·3 claims
- 2784US7910741B2Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredientONO PHARMACEUTICAL CO·Filed 2004·Granted Mar 22, 2011·24 cites·11 claims
- 2884US7119091B2Triazaspiro[5.5]undecane derivatives and pharmaceutical compositions comprising thereof, as an active ingredientONO PHARMACEUTICAL CO·Filed 2000·Granted Oct 10, 2006·24 cites·7 claims
- 2982US12325746B2Bispecific antibodyONO PHARMACEUTICAL CO·Filed 2020·Granted Jun 10, 2025·1 cites·6 claims
- 3082US7053090B2Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredientONO PHARMACEUTICAL CO·Filed 2002·Granted May 30, 2006·14 cites·4 claims
- 3181US11572393B2HMGN partial peptide and cancer therapy using the sameUNIV TOKYO·Filed 2019·Granted Feb 7, 2023·2 cites·21 claims
- 3281US11091550B2Bispecific antibodyONO PHARMACEUTICAL CO·Filed 2019·Granted Aug 17, 2021·2 cites·9 claims
- 3380US7189546B2Polypeptide, cDNA encoding the same, and use of themONO PHARMACEUTICAL CO·Filed 2003·Granted Mar 13, 2007·7 cites·5 claims
- 3479US8822459B2Compound containing basic group and use thereofKOKUBO MASAYA·Filed 2011·Granted Sep 2, 2014·4 cites·9 claims
- 3576US2024287187A1Bispecific antibodyONO PHARMACEUTICAL CO·Filed 2024·Application pending·0 cites
- 3673US8476290B2Compound having spiro-bonded cyclic group and use thereofYOSHIDA KOJI·Filed 2010·Granted Jul 2, 2013·3 cites·7 claims
- 3771US8410276B2Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredientTAKAOKA YOSHIKAZU·Filed 2011·Granted Apr 2, 2013·2 cites·4 claims
- 3871US8143404B2Nitrogenous heterocylic derivative and medicine containing the same as an active ingredientTAKAOKA YOSHIKAZU·Filed 2005·Granted Mar 27, 2012·1 cites·3 claims
- 3971US2020062846A1Immunopotentiative compositionHONJO TASUKU·Filed 2019·Application pending·0 cites
- 4070US11919932B2HMGN partial peptide and cancer therapy using the sameUNIV TOKYO·Filed 2023·Granted Mar 5, 2024·0 cites·18 claims
- 4169US8604207B2Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredientONO PHARMACEUTICAL CO·Filed 2012·Granted Dec 10, 2013·1 cites·2 claims
- 4268US8519124B2Chemokine receptor antagonists and use thereofKOKUBO MASAYA·Filed 2012·Granted Aug 27, 2013·1 cites·3 claims
- 4367US7285552B2Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredientONO PHARMACEUTICAL CO·Filed 2002·Granted Oct 23, 2007·3 cites·7 claims
- 4466US2023256054A1Immunity enhancing agent for cancer by allergin-1 antagonistONO PHARMACEUTICAL CO·Filed 2023·Application pending·0 cites
- 4565US2025368736A1Bispecific antibodyONO PHARMACEUTICAL CO·Filed 2025·Application pending·0 cites
- 4664US7732442B2Chemokine receptor antagonist and medical use thereofONO PHARMACEUTICAL CO·Filed 2004·Granted Jun 8, 2010·3 cites·3 claims
- 4763US2017051060A1Immunopotentiative CompositionHONJO TASUKU·Filed 2016·Application pending·0 cites
- 4862US12234289B2Immunosuppresive agentONO PHARMACEUTICAL CO·Filed 2019·Granted Feb 25, 2025·0 cites·12 claims
- 4962US7498323B2Spiro-piperidine compounds and medicinal use thereofONO PHARMACEUTICAL CO·Filed 2004·Granted Mar 3, 2009·1 cites·6 claims
- 5062US2003232411A1Novel polypeptide, cDNA encoding the same, and use thereofONO PHARMACEUTICAL CO·Filed 2003·Application pending·0 cites
Showing the top 50 of 86 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →